Lumos Pharma OverviewLumos Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for LUMO.
Quarterly EBIT
-$7.64M
↑ 14.54% YoY
As of Sep 30, 2024
Annual EBIT (TTM)
-$36.33M
↓ 2.44% YoY
Trailing 12 months ending Sep 30, 2024
Lumos Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for LUMO.
As of Sep 30, 2024
Trailing 12 months ending Sep 30, 2024